Diabetes Board decisions

The Board has remanded the Veteran's claims for additional development due to new evidence and outstanding records. The issues of service connection, special monthly compensation (SMC), and education benefits are being deferred until the service connection issues are resolved.

The Board has denied service connection for circulatory or vascular disability (claimed as peripheral vascular disease) and eye disability (claimed as diabetic retinopathy). The issue of service connection for peripheral neuropathy of the hands is remanded.

The Veteran's gunshot wound, left foot with Muscle Group X sensory residuals is currently rated at 30 percent and the issues regarding scar associated with the gunshot wound are also denied. The Veteran's diabetes mellitus is rated at 20 percent. His right upper extremity peripheral neuropathy is not higher than 30 percent, while his left upper extremity peripheral neuropathy is not higher than 10 percent.,The Veteran's PTSD and TDIU issues have been remanded for further development.

The Board has remanded several issues for further development, including service connection claims and the determination of a rating for diabetes mellitus. The Veteran's erectile dysfunction is granted secondary to his service-connected diabetes mellitus from September 20, 2021. Service connection for bilateral lower extremity diabetic peripheral neuropathy is granted from March 28, 2018.

The Board has decided that the Veteran's claims for service connection for left ear hearing loss and diabetes mellitus type II, to include as due to herbicide exposure, need further development. The case is being remanded to provide a new VA examination for the left ear hearing loss claim and to verify the Veteran's herbicide exposure during his service in Okinawa.

The Veteran's service-connected disabilities required the aid and attendance of his wife to feed himself, prepare meals, attend to hygiene, manage medications, dress, transfer to his scooter, and venture outside his home. The Board granted entitlement to special monthly compensation based on the need for aid and attendance.

The Veteran's petition to reopen the previously denied claim of service connection for bilateral hearing loss is denied.,The Board has remanded the issues of entitlement to service connection for diabetes mellitus type II (DM II), whether the reduction in rating was proper, and entitlement to an increased rating for residuals, right ankle subtalar dislocation with arthritis 1st metatarsophalangeal joint.

The Board has remanded the claims of service connection for diabetes mellitus, type II, peripheral neuropathy of the bilateral lower extremities, and erectile dysfunction due to a lack of verification regarding herbicide agent exposure during active service.

The Board denied service connection for fibromyalgia and diabetes, finding that the current conditions did not have an onset during or are otherwise related to active service, including exposure to contaminated water at Camp Lejeune.

The Board denied service connection for diabetes mellitus, type II due to the appellant's dishonorable discharge from military service.

The Board has remanded the claims for diabetes mellitus, right and left upper extremity neuropathy due to lack of a current diagnosis. The case must be returned after further development.

The Board has remanded the case for further development to determine if the Veteran experienced military environmental exposure to Agent Orange while serving aboard the USS Enterprise (CVAN-65). The appeal is not about service connection at all, but rather DIC under 38 U.S.C. § 1318.

The Veteran's claim for service connection for diabetes mellitus, including as due to exposure to herbicide agents, is denied. The Board found no evidence of in-service exposure to herbicide agents and concluded that the current diagnosis of diabetes mellitus was not related to service.

The Board has remanded the claims for increased rating for DM II, service connection for left and right upper extremity peripheral neuropathy as secondary to DM II, and service connection for IBS as secondary to PTSD or medication taken for DM II due to incomplete records and need for additional development.

The Veteran's right and left lower extremity diabetic peripheral neuropathy was granted a 40 percent rating from February 23, 2017, to February 4, 2018.

The Board denied service connection for diabetes mellitus, type II and ischemic heart disease as the evidence did not show exposure to herbicides during service.

The Veteran's follicular non-Hodgkin's lymphoma and diabetes mellitus type II are presumed to be connected to his in-service exposure to herbicide agents, thus service connection is granted.

The Board has remanded the claims for diabetic peripheral neuropathy in both lower extremities due to insufficient consideration of the effects of medication on symptom severity and duration, as well as the issue of total disability rating based on individual unemployability (TDIU).

The Veteran's service-connected disabilities, including PTSD and diabetes mellitus type II, have rendered him unable to secure or follow a substantially gainful occupation. The Board has remanded the case for clarification of his employment history during the appeal period and for an opinion on the functional impairment caused by these conditions.

The Board has remanded the claims for hearing loss, diabetes mellitus, peripheral neuropathy, coronary artery disease (CAD), cataracts, colon cancer, left foot pain, and PTSD due to potential service connection issues.